Accessibility Menu
 
NuVasive logo

NuVasive

(NASDAQ) NUVA

Current PriceN/A
Market CapN/A
Since IPO (2004)+249%
5 Year-43%
1 Year-6%
1 Month-3%

NuVasive Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$1.23B

Net Income (TTM)

$28.45M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

NUVA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NuVasive

Industry

Healthcare Equipment and Supplies

Employees

3,000

CEO

J. Christopher Barry

Headquarters

San Diego, CA 92121, US

NUVA Financials

Key Financial Metrics (TTM)

Gross Margin

72%

Operating Margin

5%

Net Income Margin

3%

Return on Equity

5%

Return on Capital

4%

Return on Assets

2%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$865.43M

Operating Income

$64.77M

EBITDA

$148.73M

Operating Cash Flow

$169.12M

Capital Expenditure

$139.43M

Free Cash Flow

$29.69M

Cash & ST Invst.

$248.66M

Total Debt

$1.01B

NuVasive Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2023YOY CHG

Revenue

$317.79M

+2.4%

Gross Profit

$228.31M

+1.6%

Gross Margin

71.84%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

3,000

N/A

Net Income

$7.36M

+924.6%

EBITDA

$51.41M

+58.1%

Quarterly Fundamentals

Name
Q2 2023YOY CHG

Net Cash

$825.43M

-5.9%

Accounts Receivable

$267.11M

+14.4%

Inventory

$350.81M

+5.8%

Long Term Debt

$545.36M

-0.8%

Short Term Debt

$360.79M

-20.9%

Return on Assets

1.82%

N/A

Return on Invested Capital

4.29%

N/A

Free Cash Flow

$495.00K

-101.9%

Operating Cash Flow

$36.52M

-40.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ASTHAstrana Health, Inc.
$23.92-1.08%
CALTCalliditas Therapeutics AB (publ)
$40.00-0.10%
AMAMAmbrx Biopharma Inc.
$28.00+0.07%
DCPHDeciphera Pharmaceuticals, Inc.
$25.59+0.08%

Trending Stocks

Symbol / CompanyPricePrice Chg
ANNAAleAnna
$7.22+0.91%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.17-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.72+0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.21-0.06%

Questions About NUVA

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.